Efficacy of add-on montelukast in patients with non-controlled asthma: a Belgian open-label study*

By Korn Dana   Brande Paul Van den   Potvin Emmanuel   Dramaix Michèle   Herbots Ella   Peché Rudi  

Current Medical Research and Opinion, Vol. 25, Iss. 2, 2009-02 ,pp. : 489-497

Informa Healthcare

Access to resources Recommend Favorite

Evaluation of 3–5 months’ add-on therapy with montelukast in patients with non-controlled asthma in Austria: the STAR open-label, real-world, observational study

By Schlick Werner   Pohl Wolfgang   Pfeiffer Karl P.   Aigner Kurt   Forche Günter   Kneussl Meinhard   Zwick Hartmut  

Current Medical Research and Opinion, Vol. 26, Iss. 3, 2010-03 ,pp. : 561-570

Informa Healthcare

Access to resources Recommend Favorite

Observational Study of the Additive Effects of Pranlukast on Inflammatory Markers of Clinically Stable Asthma with Inhaled Corticosteroids and Long-Acting Beta 2 Agonists

By  

Respiration, Vol. 76, Iss. 4, 2008-08 ,pp. : 398-402

Karger

Access to resources Recommend Favorite

Inhalation devices for long-acting β₂-agonists: efficiency and ease of use of dry powder formoterol inhalers for use by patients with asthma and COPD

By Molimard Mathieu   Till Denise   Stenglein Stephan   Singh Dilraj   Krummen Markus  

Current Medical Research and Opinion, Vol. 23, Iss. 10, 2007-10 ,pp. : 2405-2413

Informa Healthcare

Access to resources Recommend Favorite

Evaluating Safety of Long-Acting Beta Agonists (LABAs) in Patients with Asthma

By  

Current Drug Safety, Vol. 5, Iss. 3, 2010-07 ,pp. : 245-250

Bentham Science Publishers

Access to resources Recommend Favorite